EUCTR2012-002236-87-GB进行中（未招募）不适用
Clinical Study to Evaluate the Efficacy of Chlorhexidine Mouthwashes
GlaxoSmithKline Consumer Healthcare0 个研究点开始时间: 2012年6月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Consent
- •Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
- •Aged at least 18 years and not over 64 years.
- •3. Compliance
- •Understands and is willing, able and likely to comply with all study procedures and restrictions.
- •4. General Health
- •Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or oral/ dental examination.
- •5. Dental Health
- •a) Good oral health in the opinion of the investigator (allowing mild to moderate gingivitis to meet entry criteria).
- •b) A minimum of 20 permanent gradable teeth at screening. (Gradable teeth are those where restorative materials cover less than 25% of the tooth surface graded).
- •c) Mild to moderate gingivitis present at the screening visit in the opinion of the investigator.
- •d) Positive response to bleeding on brushing exercise at screening visit.
- •e) A total of 20 bleeding sites or greater at baseline visit.
- •6. Contraception
- •Females of childbearing potential who are, in the opinion of the investigator, practising a reliable method of contraception. Adequate contraception is defined as abstinence, oral contraceptive, either combined or progestogen alone OR injectable progestogen OR implants of levonorgestrel OR estrogenic vaginal ring OR percutaneous contraceptive patches OR intrauterine device or intrauterine system OR double barrier method (condom or occlusive cap [diaphragm or cervical vault caps] plus spermicidal agent [foam, gel, film, cream, suppository]) OR male partner sterilization prior to the female subject's entry into the study, and this male is the sole partner for that subject.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 360
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Pregnancy
- •Women who are pregnant, intending to become pregnant or who have a positive urine pregnancy test at the screening, baseline or prophylaxis visits.
- •2. Breast-feeding
- •Women who are breast–feeding.
- •3. Allergy/Intolerance
- •Known or suspected intolerance or hypersensitivity to Chlorhexidine or other study materials (or closely related compounds) or any of their stated ingredients.
- •4. Clinical Study/Experimental Medication
- •a) Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit.
- •b) Previous participation in this study.
- •5. Medical History/ Current Medications
- •a) Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any other medical condition (e.g. Diabetes Mellitus) that would make the subject unlikely to fully complete the study or any that increases the risk to the subject or undermines the data validity.
- •b) Subjects requiring prophylactic antibiotic treatment prior to dental therapy.
- •c) Use of concomitant medication that, in the opinion of the investigator, might interfere with the outcome of the study or increases the risk to the subject (eg: phenytoin, calcium antagonists, cyclosporine, warfarin, antibiotics, immuno-suppressants).
- •d) Use of antibiotics within two weeks prior to the screening visit or throughout the study.
- •e) Use of any systemic medication which would have an effect on gingival conditions within 14 days of gingival examinations (eg: ibuprofen or aspirin therapy)
- •6. Dental Health
- •a) Have current active caries
- •b) More than 3 pockets with 5mm or over.
- •c) Excessive calculus present that interferes with the probing examination for Gingival Index.
- •d) Other severe oral/ gingival conditions (e.g. Acute Necrotizing Ulcerative Gingivitis) that may compromise the study or the subjects in the opinion of the investigator or gingivitis examiner.
- •e) Medical conditions which may directly influence gingival bleeding.
- •f) Restorations in a poor state of repair.
- •g) Orthodontic appliances anterior cosmetic restorations and veneers.
- •h) Enamel pitting/irregularities.
- •7. Tobacco Chewers
- •Subjects using chewing tobacco, pan, pan-masala, gutkha or other chewing tobacco products or subjects who have quit using any of those within the past six months prior to screening.
- •8. Substance abuse
- •Recent history (within the last year) of alcohol or other substance abuse.
- •9. Personnel
- •a) An employee of the sponsor or the study site or members or their immediate family.
- •b) An employee of any toothpaste manufacturer or their immediate family.
研究者
相似试验
已完成
1 期
use of different treatment techniques on same patient to reduce gum infection of patient undergoing orthodontic treatmentCTRI/2018/02/012191Sreedevi K20
尚未招募
3 期
Evaluation Between Chlorhexidine Gel And Herbal Gel for Periodontal TreatmentCTRI/2024/05/067879Datta Meghe Institute of Higher Education and Research
尚未招募
4 期
A comparative study between chlorhexidine coated absorbable and non chlorhexidine coated suture in controlling infections after surgical extractionsCTRI/2022/10/046594A B Shetty Memorial Institute Of Dental Sciences
招募中
不适用
Evaluation of dressing for central venous catheterCatheter-related bloodstream infectionC01.539.195RBR-7b5yczniversidade Federal do Paraná
已完成
不适用
chloral hydrate, combination of chloral hydrate - promethazine and combination of chloral hydrate - hydroxyzine in sedation induction for electroencephalography of childreepilepsy.Epilepsy and paroxysmal disordersG40, G47IRCT201204262639N8Ali-ebn-Abitaleb School of Medicine, Islamic Azad University, Yazd Branch, Yazd, Iran90